Clinical trial
Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
NCT04174456 is registered in ClinicalTrials.gov with Dong-A University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
- Lead sponsor
- Dong-A University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2019
- Completion date
- December 31, 2021
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dilated cardiomyopathy